Safety study of a new medicine in healthy volunteers
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good overall health, with no major illnesses like heart disease, diabetes, or cancer.
- Your weight must be at least 40 kg (which is about 88 pounds), and your BMI must be between 18 and 32.
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the study or for 6 months after.
- You must test negative for hepatitis B, hepatitis C, HIV, and be free of active or latent tuberculosis.
- You should not have received any live vaccines in the past month, or any other vaccines in the past 2 weeks.
- You cannot have had a major illness or fever in the last month before the screening visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new drug called RO7875913 in healthy volunteers to find the safest dose. It helps researchers understand how the drug works in the body before moving to studies in people with the disease.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.